{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-09",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Deerfield",
      "state": "IL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "NDA217569"
        ],
        "brand_name": [
          "VASOPRESSIN IN 0.9% SODIUM CHLORIDE"
        ],
        "generic_name": [
          "VASOPRESSIN IN 0.9% SODIUM CHLORIDE"
        ],
        "manufacturer_name": [
          "Baxter Healthcare Corporation"
        ],
        "product_ndc": [
          "0338-9640",
          "0338-9647"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "VASOPRESSIN"
        ],
        "rxcui": [
          "2399907",
          "2591428"
        ],
        "spl_id": [
          "e5fb5b63-6f2e-4ebe-9a55-147a793e95dd"
        ],
        "spl_set_id": [
          "b5b2c367-6b7e-40be-a296-c4632f3e783f"
        ],
        "package_ndc": [
          "0338-9640-12",
          "0338-9647-12"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "M0022562",
          "N0000009908",
          "N0000175360"
        ],
        "pharm_class_cs": [
          "Vasopressins [CS]"
        ],
        "pharm_class_pe": [
          "Vasoconstriction [PE]",
          "Decreased Diuresis [PE]"
        ],
        "unii": [
          "Y4907O6MFD"
        ]
      },
      "product_type": "Drugs",
      "event_id": "99500",
      "recalling_firm": "Baxter Healthcare Corporation",
      "address_1": "1 Baxter Pkwy",
      "address_2": "N/A",
      "postal_code": "60015-4625",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "US Nationwide; Puerto Rico; and Chile.",
      "recall_number": "D-0819-2026",
      "product_description": "Vasopressin, in 0.9% Sodium Chloride Injection, 40 units per 100 mL (0.4 units/mL), 100mL Single-Dose Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60015 USA, NDC 0338-9647-12.",
      "product_quantity": "N/A",
      "reason_for_recall": "CGMP Deviations",
      "recall_initiation_date": "20260806",
      "center_classification_date": "20260828",
      "report_date": "20260909",
      "code_info": "Lot # NC185448, Exp Date: 8/31/2027; Lot # NC192910, Exp Date: 4/30/2028; Lot # NC195218, Exp Date: 6/30/2028.",
      "more_code_info": ""
    }
  ]
}